Stock CARM CARISMA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Carisma Therapeutics, Inc.

Equities

CARM

US14216R1014

Real-time Estimate Cboe BZX
Other stock markets
 10:05:32 2024-05-20 am EDT 		5-day change 1st Jan Change
1.435 USD +1.77% Intraday chart for Carisma Therapeutics, Inc. -4.73% -51.88%
May. 16 Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, A Novel HER2-Targeting CAR-Monocyte CI
May. 09 Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
CI
Carisma Therapeutics, Inc. Announces Changes to Its Board of Directors
CI
Carisma Therapeutics Inc. Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources
CI
Sesen Bio, Inc. Announces Executive Changes
CI
Sesen Bio, Inc. Appoints Dominika Kowalski as Senior Director of Global Drug Safety
CI
Sesen Bio, Inc. Announces Director Jane Pritchett Henderson Transitions to CEO Advisor Role
CI
Sesen Bio Announces Director Appointments
CI
Sesen Bio Hires John Knighton as Chief Compliance Officer, Effective August 16, 2021
CI
Sesen Bio Hires of Amy Ponpipom as Vice President, Assistant General Counsel
CI
Sesen Bio, Inc. Announces New Appointments to Its Board of Directors
CI
Sesen Bio, Inc. Strengthens Senior Leadership Team
CI
Sesen Bio, Inc. Announces Executive Changes
CI
Sesen Bio, Inc. Announces Board Changes
CI
Sesen Bio, Inc. Announces Management Changes
CI
Sesen Bio, Inc. Announces Executive Appointments
CI
Sesen Bio, Inc. Announces the Retirement of Leslie Dan from Board of Directors as Class I Director
CI
Sesen Bio, Inc. Appoints Dennis Kim as Chief Medical Officer
CI
Sesen Bio, Inc. Announces Management Changes
CI
Sesen Bio Announces Executive Appointments
CI
Eleven Biotherapeutics, Inc. has Changed its Name to Sesen Bio, Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CARM Stock
  4. News Carisma Therapeutics, Inc.
  5. Insiders
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW